Welcome

Celebrating Over 75 Years Of Service

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

ADVOCACY UPDATES

USP Update

Final Standards for Allergen Extract Compounding under USP Chapter 797 The long-awaited new USP Chapter…

read more

Impact OF 2019 Physician Fee Schedule on Allergy and Sinus Services

Specialty Impact The conversion factor for 2019 will be $36.0391 and remains essentially flat.  The changes…

read more

Your AAOA at the AMA

I want to urge you to consider membership in the AMA because your membership in…

read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

04/15/20: Fellow Exam Application Deadline
Learn more

06/01/20: Research Grant Cycle
Learn more

06/26/20: Membership Application Deadline to be eligible for AAOA Member rate for the 2020 Basic Course Learn more

07/15/20: Call for Scientific Papers
Learn more

09/11/20: Membership Application Deadline to be voted in at the 2020 Annual Meeting and to be eligible for AAOA Member Rate (FREE) for the 2020 Annual Meeting Learn more

12/01/20: Research Grant Cycle
Learn more

EDUCATION

New Virtual Course!

Register now as we build out Part 2 Core Allergy & Part 3 Core Rhinology.   Both promise to deliver clinical content you need.  Core Allergy will offer what you need to help refresh or add allergy to your practice — everything from the clinical science to the basics of allergy from a better understanding of testing techniques, vial prep, and dose calculations to other practical implications.  Core Rhinology encompassed the highly sought after rhinology content from our former IAR program.  Part 1 will launch soon with on demand content to help you balance all your time demands.  Part 2 & 3 will feature live-stream content to give you opportunities to interact with the faculty.  Post live session, this content will also be available on demand. Stay tuned for more details as we finish our program build. Read More

IFAR

IFAR Impact Factor: 2.454

aaoaf-ifar

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Now Available

Changes in Managing Practices

Mission

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

NEW VIRTUAL COURSE! Core Allergy and Rhinology Concepts: Age of Pandemics and Beyond
Learn How to Reboot Your Practice and Freshen Up on Core Allergy and Rhinology Components
Learn More and Register

2020 Basic Course in Allergy & Immunology
July 9-11 | Orlando, FL
COVID-19 has made it impossible to convene our 2020 Basic Course. We hope you will consider another AAOA CME opportunity

2020 AAOA Annual Meeting
October 23-25| Scottsdale, AZ
Learn More and Register

2020 Advanced Course in Allergy & Immunology
December 9-12 | Vail, CO
Learn More and Register

AAOA Clinical Insights
Learn More and Register

USP 797 Online Module
Learn More and Register

2021 Basic Course in Allergy & Immunology
July 15-17 | Seattle, WA

News and Updates

Top research published in the International Forum of Allergy & Rhinology (IFAR)

Read top research published in the International Forum of Allergy & Rhinology, 2018-2019: Top 5 Downloaded…

read more

The Excitement of the Recent AAOA Annual Meeting is Still Upon Us…

The AAOA is an organization committed to your professional growth and provides you with the knowledge and tools to make a meaningful impact for the patients you serve.
read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PATIENT CORNER

Menu

FDA Approval of First and Only Digital Inhaler with Built-In Sensors

The Food and Drug Administration (FDA) has approved ProAir Digihaler (albuterol sulfate) inhalation powder for the treatment or prevention of bronchospasm in patients aged 4 years and older with reversable obstructive airway disease, and for prevention of exercise-induced bronchospasm (EIB) in patients aged 4 years and older. The approval was based on the review of a supplemental New Drug Application (sNDA). 

ProAir Digihaler, Teva Pharmaceuticals, is the first digital inhaler with built-in sensors that connects to a mobile application and provides data on inhaler use to patients with asthma and chronic obstructive pulmonary disease (COPD). The product combines a breath-activated, multi-dose dry powder inhaler with albuterol along with a built-in electronic module and a companion app. The sensors detect and record when the inhaler is used and measure inspiratory flow; this data is then sent to the companion application via Bluetooth Wireless Technology so patients can review their data and share it with their healthcare professionals.